Search Log In

fig2

From:  Long-term immune-modulatory side effects of radiofrequency ablation in patients with liver metastases and hepatocellular carcinoma
Long-term immune-modulatory side effects of radiofrequency ablation in patients with liver metastases and hepatocellular carcinoma

Figure 2. Cytolytic activity of T cells measured by adenylate kinase (AK) release assay. AK release was quantifi ed by luminescence and expressed as RLU. A significant difference between patients with recurrence of malignancy and patients with disease-free survival is shown after 12 months (P < 0.05) only. Shown are mean ± SD. RFA: radiofrequency ablation; RLU: relative luminescence units

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties